News and Views
Nature Medicine 13, 1281 - 1282 (2007)
doi:10.1038/nm1107-1281
A deer in the headlights: BAMBI meets liver fibrosis
Scott L Friedman1
- Scott L. Friedman is in the Division of Liver Diseases, Department of Medicine, Mount Sinai School of Medicine, Box 1123, 1425 Madison Ave., Room 1170C, New York, New York 10029-6574, USA. e-mail: scott.friedman@mssm.edu
Abstract
Lipopolysaccharide signaling through the Toll-like receptors downregulates an inhibitory pseudoreceptor of TGF-
, enhancing hepatic fibrosis and liver injury (pages 1324–1332).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
DNA microarray analyses of genes expressed differentially in 3T3-L1 adipocytes co-cultured with murine macrophage cell line RAW264.7 in the presence of the toll-like receptor 4 ligand bacterial endotoxinInternational Journal of Obesity Scientific Correspondence
TLR4 enhances TGF-β signaling and hepatic fibrosisNature Medicine Article (01 Nov 2007)
